Michael N Robertson Selected Research

Michael N Robertson Research Topics

Disease

39	Infections 03/2023 - 04/2004
8	HIV Infections (HIV Infection) 01/2023 - 07/2003
8	Chronic Hepatitis C 11/2020 - 07/2015
8	Fibrosis (Cirrhosis) 01/2020 - 08/2014
3	Hepatitis C 01/2022 - 01/2016
3	Mycoses (Diseases, Fungus) 12/2017 - 07/2014
2	Communicable Diseases (Infectious Diseases) 01/2023 - 01/2012
2	Virus Diseases (Viral Diseases) 01/2019 - 02/2003
2	Coinfection 11/2017 - 08/2015
2	Viremia 03/2008 - 04/2004
1	Reinfection 01/2022
1	Chronic Renal Insufficiency 11/2020
1	Insulin Resistance 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Chest Pain (Chest Pains) 01/2018
1	Cellulitis 01/2018
1	Opiate Overdose 01/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2017
1	Pain (Aches) 03/2014
1	Malaria 01/2012
1	Tuberculosis (Tuberculoses) 01/2012
1	Disease Progression 04/2011
1	HIV Seropositivity 12/2008
1	Fatigue 09/2007
1	Hyperlipidemias (Hyperlipidemia) 07/2003

Drug/Important Bio-Agent (IBA)

21	grazoprevirIBA 03/2023 - 08/2014
19	elbasvirIBA 03/2023 - 07/2015
13	VaccinesIBA 01/2013 - 04/2004
11	Ribavirin (Virazole)FDA LinkGeneric 03/2023 - 08/2014
9	Antiviral Agents (Antivirals)IBA 01/2022 - 09/2015
5	InterferonsIBA 01/2019 - 07/2015
4	uprifosbuvirIBA 01/2019 - 11/2017
4	ruzasvirIBA 01/2019 - 11/2017
4	RNA (Ribonucleic Acid)IBA 11/2017 - 04/2011
3	islatravirIBA 01/2023 - 01/2021
3	Lamivudine (Epivir)FDA Link 01/2022 - 07/2003
3	Opioid Analgesics (Opioids)IBA 01/2022 - 11/2016
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2017
3	posaconazole FDA Link 12/2017 - 07/2014
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2016 - 07/2003
2	AIDS VaccinesIBA 01/2023 - 07/2012
2	AntigensIBA 01/2023 - 02/2003
2	doravirineIBA 01/2022 - 01/2021
2	DNA VaccinesIBA 03/2014 - 03/2008
1	Amino Acids FDA Link 03/2023
1	2'-deoxyadenosineIBA 01/2023
1	NucleosidesIBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	NucleotidesIBA 01/2019
1	Oral ContraceptivesIBA 01/2019
1	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 01/2019
1	Drug CombinationsIBA 01/2019
1	SofosbuvirIBA 01/2018
1	CreatinineIBA 01/2018
1	Proton Pump InhibitorsIBA 10/2017
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 09/2015
1	SimeprevirIBA 09/2015
1	telaprevirIBA 09/2015
1	SolutionsIBA 07/2014
1	CyclodextrinsIBA 07/2014
1	Phosphates (Orthophosphate)IBA 03/2014
1	EpitopesIBA 01/2013
1	AntibodiesIBA 07/2012
1	SAIDS VaccinesIBA 02/2012
1	Viral RNAIBA 02/2012
1	CytokinesIBA 11/2008
1	DNA (Deoxyribonucleic Acid)IBA 04/2004
1	Protein Subunits (Protein Subunit)IBA 04/2004
1	Indinavir (Crixivan)FDA Link 07/2003
1	Triglycerides (Triacylglycerol)IBA 07/2003
1	Zidovudine (Retrovir)FDA LinkGeneric 07/2003

Therapy/Procedure

10	Therapeutics 01/2022 - 07/2003
2	Aftercare (After-Treatment) 01/2022 - 07/2003
1	Opiate Substitution Treatment 01/2022
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2019
1	Highly Active Antiretroviral Therapy (HAART) 09/2007